[1. Kaemmerer H, Meisner H, Hess J, Perloff JK. Surgical treatment of patent ductus arteriosus: a new historical perspective. Am J Cardiol. 2004;94:1153-4.10.1016/j.amjcard.2004.07.082]Search in Google Scholar
[2. Schneider DJ, Moore JW. Patent Ductus Arteriosus. Circulation 2006;114:1873-82. DOI: 10.1161/CIRCULATIONAHA.105.592063.10.1161/CIRCULATIONAHA.105.592063]Search in Google Scholar
[3. Hillman M, Meinarde L, Rizzotti A, Cuestas E. Inflammation, High-sensitivity C-reactive Protein, and Persistent Patent Ductus Arteriosus in Preterm Infants. Rev Esp Cardiol (Engl Ed). 2016;69:84-5. doi: 10.1016/j.rec.2015.09.014.10.1016/j.rec.2015.09.014]Search in Google Scholar
[4. Al Nemri AMH. Patent ductus arteriosus in preterm infant: Basic pathology and when to treat. Sudan J Paediatr. 2014;14:25-30.]Search in Google Scholar
[5. Abdel-Hady H, Nasef N, Shabaan AE, Nour I. Patent Ductus Arteriosus in Preterm Infants: Do We Have the Right Answers? BioMed Research International 2013. http://dx.doi.org/10.1155/2013/676192.]Search in Google Scholar
[6. Dice JE, Bhatia J. Patent Ductus Arteriosus: An Overview. J Pediatr Pharmacol Ther. 2007;12:138-46. doi: 10.5863/1551-6776-12.3.13810.5863/1551-6776-12.3.138]Search in Google Scholar
[7. Fanos V, Pusceddu M, Dessi A, Marcialis MA. Should we definitively abandon prophylaxis for patent ductus arteriosus in preterm new-borns? Clinics. 2011;66:2141-9. http://dx.doi.org/10.1590/S1807-59322011001200022.]Search in Google Scholar
[8. Hermes-DeSantis ER, Clyman RI. Patent ductus arteriosus: pathophysiology and management. J Perinatol. 2006;26:S14-8. DOI: 10.1038/sj.jp.721146510.1038/sj.jp.7211465]Search in Google Scholar
[9. Clyman RI. Ibuprofen and patent ductus arteriosus. N Engl J Med. 2000;343:728-39. DOI: 10.1056/NEJM20000907343100910.1056/NEJM200009073431009]Search in Google Scholar
[10. Hoffman JI, Kaplan S. The incidence of congenital heart disease. J Am Coll Cardiol. 2002;39:1890-900.10.1016/S0735-1097(02)01886-7]Search in Google Scholar
[11. Fortescue EB, Lock JE, Galvin T, McElhinney DB. To Close or Not to Close: The Very Small Patent Ductus Arteriosus. Congenit Heart Dis. 2010;5:354-65. doi: 10.1111/j.1747-0803.2010.00435.x.10.1111/j.1747-0803.2010.00435.x424022420653702]Search in Google Scholar
[12. Toganel R. Critical Congenital Heart Diseases as Lifethreatening Conditions in the Emergency Room. Journal of Cardiovascular Emergencies. 2016;2:7-10. DOI: 10.1515/jce-2016-0002.10.1515/jce-2016-0002]Search in Google Scholar
[13. Feng YS, Yu V. Management of Patent Ductus Arteriosus in Very Preterm Infants in the Post-surfactant Era. HK J Paediatr (new series). 2003;8:93-100.]Search in Google Scholar
[14. Hammoud MS, Elsori HA, Hanafi E-AM, Shalabi AA, Fouda IA, Devarajan LV. Incidence and risk factors associated with the patency of ductus arteriosus inpreterm infants with respiratory distress syndrome in Kuwait. Saudi Med J. 2003;24:982-5.]Search in Google Scholar
[15. Lee JA, Kim M-J, Oh S, Choi BM. Current Status of Therapeutic Strategies for Patent Ductus Arteriosus in Very-Low-Birth-Weight Infants in Korea. J Korean Med Sci. 2015;30:S59-66. doi: 10.3346/jkms.2015.30.S1.S59.10.3346/jkms.2015.30.S1.S59464106526566359]Search in Google Scholar
[16. Nizarali Z, Marques T, Costa C, Barroso R, Cunha M. Patent Ductus Arteriosus: Perinatal Risk Factors. J Neonatal Biol. 2012;1:3. http://dx.doi.org/10.4172/2167-0897.1000109.]Search in Google Scholar
[17. Evans N. Preterm patent ductus arteriosus: should we treat it? J Paediatr and Child Health. 2012;48:753-8. doi: 10.1111/j.1440-1754.2012.02542.x.10.1111/j.1440-1754.2012.02542.x22970669]Search in Google Scholar
[18. Meyer S. PDA in neonates—please doctor act individually! Acta Paediatr. 2012;101:e145-6. DOI: 10.1111/j.1651-2227.2012.02617.x.10.1111/j.1651-2227.2012.02617.x]Search in Google Scholar
[19. Koch J, Hensley G, Roy L, Brown S, Ramaciotti C, Rosenfeld CR. Prevalence of spontaneous closure of the ductus arteriosus in neonates at a birth weight of 1000 grams or less. Pediatrics. 2006;117:1113-21. DOI: 10.1542/peds.2005-1528.10.1542/peds.2005-152816585305]Search in Google Scholar
[20. Hamrick SE, Hansmann G. Patent ductus arteriosus of the preterm infant. Pediatrics. 2010;125:1020-30. doi: 10.1542/peds.2009-3506.10.1542/peds.2009-350620421261]Search in Google Scholar
[21. Chen H-L, Yang R-C, Lee W-T, et al. Lung function in very preterm infants with patent ductus arteriosus under conservative management: an observational study. BMC Pediatrics. 2015;15:167. DOI: 10.1186/s12887-015-0480-y.10.1186/s12887-015-0480-y462000126496854]Search in Google Scholar
[22. Du J-F, Liu T-T, Wu H. Risk factors for patent ductus arteriosus in early preterm infants: a case-control study. Zhongguo Dang Dai Er Ke Za Zhi. 2016;18:15-9.]Search in Google Scholar
[23. Garcıa-Munoz RF, Galan HG, Figueras AJ, Garcıa-Alix PA. Outcomes of very-low-birth-weight infants exposed to maternal clinical chorioamnionitis: a multicentre study. Neonatology 2014;106:229-34. doi: 10.1159/000363127.10.1159/00036312725011418]Search in Google Scholar
[24. Park HW, Choi Y-S, Kim KS, Kim S-N. Chorioamnionitis and Patent Ductus Arteriosus: A Systematic Review and Meta-Analysis. PLoS ONE. 2015;10:e0138114. doi: 10.1371/journal.pone.0138114.10.1371/journal.pone.0138114457416726375582]Search in Google Scholar
[25. Gonzalez A, Sosenko IR, Chandar J, et al. Influence of infection on patent ductus arteriosus and chronic lung disease in premature infants weighing 1000 grams or less. J Pediatr. 1996;128:470-8.10.1016/S0022-3476(96)70356-6]Search in Google Scholar
[26. Seppanen MP, Ojanpera OS, Kaapa PO, Kero PO. Delayed postnatal adaptation of pulmonary hemodynamics in infants of diabetic mothers. J Pediatr. 1997;131:545-8.10.1016/S0022-3476(97)70059-3]Search in Google Scholar
[27. Rakza T, Magnenant E, Klosowski S, Tourneux P, Bachiri A, Storme L. Early hemodynamic consequences of patent ductus arteriosus in preterm infants with intrauterine growth restriction. J Pediatr. 2007;151:624-8. DOI: 10.1016/j.jpeds.2007.04.058.10.1016/j.jpeds.2007.04.058]Search in Google Scholar
[28. Agarwal R, Deorari AA, Paul VK. Patent Ductus Arteriosus in Preterm Neonates. Indian J Pediatr. 2008;75:277. doi: 10.1007/s12098-008-0059-9.10.1007/s12098-008-0059-9]Search in Google Scholar
[29. Saeidi R, Mahmoodi E, Eslami M, Gholami M. Evaluation of Risk Factors Related with Neonatal Patent Ductus Arteriosus in Hospitalized Neonates of Neonatal Intensive Care Unit. Zahedan J Res Med Sci (ZJRMS). 2012;14:33-5.]Search in Google Scholar
[30. Bell EF, Acarregui MJ. Restricted versus liberal water intake for preventing morbidity and mortality in preterm infants. Cochrane Database Syst Rev. 2008;(1):CD000503. doi: 10.1002/14651858.CD000503.pub2.10.1002/14651858.CD000503.pub2]Search in Google Scholar
[31. Green TP, Thompson TR, Johnson DE, Lock JE. Furosemide promotes patent ductus arteriosus in premature infants with the respiratory distress syndrome. N Engl J Med. 1983;308:743-8.10.1056/NEJM198303313081303]Search in Google Scholar
[32. Simon SR, van Zogchel L, Bas-Suárez MP, Cavallaro G, Clyman RI, Villamor E. Platelet Counts and Patent Ductus Arteriosus in Preterm Infants: A Systematic Review and Meta-Analysis. Neonatology. 2015;108:143-51. doi: 10.1159/000431281.10.1159/000431281]Search in Google Scholar
[33. Shimada S, Kasai T, Hoshi A, Murata A, Chida S. Cardiocirculatory effects of patent ductus arteriosus in extremely low-birth-weight infants with respiratory distress syndrome. Pediatr Int. 2003;45:255-62.10.1046/j.1442-200X.2003.01713.x]Search in Google Scholar
[34. Noori S, Patel D, Friedlich P, Siassi B, Seri I, Ramanathan R. Effects of low oxygen saturation limits on the ductus arteriosus in extremely low birth weight infants. J Perinatol. 2009;29:553-7. doi: 10.1038/jp.2009.60.10.1038/jp.2009.60]Search in Google Scholar
[35. Kaapa P, Seppanen M, Kero P, Saraste M. Pulmonary hemodynamics after synthetic surfactant replacement in neonatal respiratory distress syndrome. J Pediatr. 1993;123:115-9.10.1016/S0022-3476(05)81553-7]Search in Google Scholar
[36. Soll R, Özek E. Prophylactic protein free synthetic surfactant for preventing morbidity and mortality in preterm infants. Cochrane Database Syst Rev. 2010;(1):CD001079. doi: 10.1002/14651858.CD001079.pub2.10.1002/14651858.CD001079.pub2705918120091513]Search in Google Scholar
[37. Rosenfeld W, Sadhev S, Brunot V, Jhaveri R, Zabaleta I, Evans HE. Phototherapy effect on the incidence of patent ductus arteriosus in premature infants: prevention with chest shielding. Pediatrics. 1986;78:10-4.10.1542/peds.78.1.10]Search in Google Scholar
[38. Sadecka LSR, Leoneb CR, Procianoyc RS, et al. Effects of therapeutic approach on the neonatal evolution of very low birth weight infants with patent ductus arteriosus. J Pediatr (Rio J). 2014;90:616-23. doi: 10.1016/j.jped.2014.04.010.10.1016/j.jped.2014.04.01025046256]Search in Google Scholar
[39. Hajjar ME, Vaksmann G, Rakza T, Kongolo G, Storme L. Severity of the ductal shunt: a comparison of different markers. Arch Dis Child Fetal Neonatal Ed. 2005;90:F419-22. DOI: 10.1136/adc.2003.027698.10.1136/adc.2003.027698172194416113155]Search in Google Scholar
[40. Kluckow M, Evans N. Ductal shunting, high pulmonary blood flow, and pulmonary hemorrhage. J Pediatr. 2000;137:68-72.10.1067/mpd.2000.10656910891824]Search in Google Scholar
[41. Mosalli R, Alfaleh K. Prophylactic surgical ligation of patent ductus arteriosus for prevention of mortality and morbidity in extremely low birth weight infants. Cochrane Database Syst Rev. 2008;(1):CD006181. doi: 10.1002/14651858.CD006181.pub2.10.1002/14651858.CD006181.pub2891621818254095]Search in Google Scholar
[42. Noori S. Patent ductus arteriosus in the preterm infant: to treat or not to treat? J Perinatol. 2010;30 Suppl:S31-7. doi: 10.1038/jp.2010.97.10.1038/jp.2010.9720877405]Search in Google Scholar
[43. Dollberg S, Lusky A, Reichman B. Patent ductus arteriosus, indomethacin and necrotizing enterocolitis in very low birth weight infants: a population-based study. J Pediatr Gastroenterol Nutr. 2005;40:184-8.10.1097/00005176-200502000-0001915699694]Search in Google Scholar
[44. McPherson C, Gal P, Smith M, et al. Necrotizing Entrocolitis and Intestinal Perforation in Preterm Infants with Patent Ductus Arteriosus: Does indomethacin increase the risk? Journal of Neonatal-Perinatal Medicine. 2008;1:209-16.]Search in Google Scholar
[45. Sellmer A, Bjerre JV, Schmidt MR, et al. Morbidity and mortality in preterm neonates with patent ductus arteriosus on day 3. Arch Dis Child Fetal Neonatal Ed. 2013;98:F505-10. doi: 10.1136/archdischild-2013-303816.10.1136/archdischild-2013-30381623893268]Search in Google Scholar
[46. Evans N, Kluckow M. Early ductal shunting and intraventricular haemorrhage in ventilated preterm infants. Arch Dis Child Fetal Neonatal Ed. 1996;75:F183-6.10.1136/fn.75.3.F183]Search in Google Scholar
[47. Noori S, McCoy M, Friedlich P, et al. Failure of ductus arteriosus closure is associated with increased mortality in preterm infants. Pediatrics. 2009;123:e138-44. doi: 10.1542/peds.2008-2418.10.1542/peds.2008-2418]Search in Google Scholar
[48. Benitz WE. Treatment of persistent patent ductus arteriosus in preterm infants: time to accept the null hypothesis? J Perinatol. 2010;30:241-52. doi: 10.1038/jp.2010.3.10.1038/jp.2010.3]Search in Google Scholar
[49. Clyman RI, Couto J, Murphy GM. Patent ductus arteriosus: are current neonatal treatment options better or worse than no treatment at all? Semin Perinatol. 2012;36:123-9. doi: 10.1053/j.semperi.2011.09.022.10.1053/j.semperi.2011.09.022]Search in Google Scholar
[50. Ivey KN, Srivastava D. The paradoxical patent ductus arteriosus. J Clin Invest. 2006;116:2863-5. Doi: 10.1172/JCI30349.10.1172/JCI30349]Search in Google Scholar
[51. Vermont-Oxford trials network database project. Manual of Operations, Release 2.0. Neonatal Research and Technology Assessment, Inc. Burlington, 1993.]Search in Google Scholar
[52. Nemerofsky SL, Parravicini E, Bateman D, Kleinman C, Polin RA, Lorenz JM. The ductus arteriosus rarely requires treatment in infants > 1000 grams. Am J Perinatol. 2008;25:661-6. doi: 10.1055/s-0028-1090594.10.1055/s-0028-1090594]Search in Google Scholar
[53. Fanaroff AA, Hack M, Walsh MC. The NICHD Neonatal Research Network: changes in practice and outcomes during the first 15 years. Semin Perinatol. 2003;27:281-7.10.1016/S0146-0005(03)00055-7]Search in Google Scholar
[54. Popat H, Kapoor V, Travadi J. Patent Ductus Arteriosus in Infants <29 Weeks Gestation –Outcomes and Factors Affecting Closure. Indian Pediatr. 2012;49:615-20.10.1007/s13312-012-0132-322317982]Search in Google Scholar
[55. Eronen M, Kari A, Pesonen E, Hallman M. The effect of antenatal dexamethazone administration on the fetal and neonatal ductus arteriosus. A randomized double-blind study. Am J Dis Child. 1993;147:187-92.10.1001/archpedi.1993.021602600770268427243]Search in Google Scholar
[56. Halliday HL, Ehrenkranz RA, Doyle LW. Early (< 8 days) postnatal corticosteroids for preventing chronic lung disease in preterm infants. Cochrane Database Syst Rev. 2009;(1):CD001146. doi: 10.1002/14651858.CD001146.pub2.10.1002/14651858.CD001146.pub219160190]Search in Google Scholar
[57. Kim ES, Kim EK, Choi CW, et al. Intrauterine inflammation as a risk factor for persistent ductus arteriosus patency after cyclooxygenase inhibition in extremely low birth weight infants. J Pediatr. 2010;157:745-50.e1. doi: 10.1016/j.jpeds.2010.05.020.10.1016/j.jpeds.2010.05.02020598319]Search in Google Scholar
[58. Shah DM, Shenai JP, Vaughn WK. Neonatal outcome of premature infants of mothers with preeclampsia. J Perinatol. 1995;15:264-7.]Search in Google Scholar
[59. Tsai M-L, Lien R, Chiang M-C, et al. Prevalence and Morbidity of Late Preterm Infants: Current Status in a Medical Center of Northern Taiwan. Pediatr Neonatol. 2012;53:171-7. doi: 10.1016/j.pedneo.2012.04.003.10.1016/j.pedneo.2012.04.00322770105]Search in Google Scholar
[60. Ognean ML, Stoicescu SM, Boanta O, Nastase L, Gliga C, Cucerea M. Intubation-Surfactant: Extubation on Continuous Positive Pressure Ventilation. Who are the best candidates? J Crit Care Med. 2016;2:73-9. DOI: 10.1515/jccm-2016-0010.10.1515/jccm-2016-0010593913029967841]Search in Google Scholar
[61. Pegoli W. Pericardium and great vessels. In: Oldham KT, Colombiani PM, et al. (eds). Principles and Practice of Pediatric Surgery. 4th ed. Philadelphia, PA: Lippincott Williams & Wilkins 2005; 1019.]Search in Google Scholar
[62. Smith GC. The pharmacology of the ductus arteriosus. Pharmacol Rev. 1998;50:35-58.]Search in Google Scholar
[63. Sweet Dg, Carnielli V, Greisen G, et al. European consensus guidelines on the management of neonatal respiratory distress syndrome in preterm infants--2013 update. Neonatology. 2013;103:353-68. doi: 10.1159/000349928.10.1159/00034992823736015]Search in Google Scholar
[64. Tauzin L, Joubert C, Noel A-C, Bouissou A, Moulies M-E. Effect of persistent patent ductus arteriosus on mortality and morbidity in very low-birthweight infants. Acta Paediatr. 2012;101:419-23. doi: 10.1111/j.1651-2227.2011.02550.x.10.1111/j.1651-2227.2011.02550.x22133090]Search in Google Scholar
[65. Ferreira CH, Carmona F, Martinez FE. Prevalence, risk factors and outcomes associated with pulmonary hemorrhage in newborns. J Pediatr (Rio J). 2014;90:316-22. doi: 10.1016/j.jped.2013.12.008.10.1016/j.jped.2013.12.00824606947]Search in Google Scholar
[66. Zahr RA, Marron-Corwin M. Neonatal pulmonary hemorrhage. NeoReviews 2012;13:e302-6. doi: 10.1542/neo.13-5-e302.10.1542/neo.13-5-e302]Search in Google Scholar
[67. Stucin Gantar I, Babnik J, Kornhauser Cerar L, Sinkovec J, Wraber B. Prenatal and postnatal risk factors for developing bronchopulmonary dysplasia. Signa Vitae. 2011;6:46-51.10.22514/SV62.102011.6]Search in Google Scholar
[68. Ohlsson A, Walia R, Shah SS. Ibuprofen for the treatment of patent ductus arteriosus in preterm and/or low birth weight infants. Cochrane Database Syst Rev. 2013;(4):CD003481. doi: 10.1002/14651858.CD003481.pub5.10.1002/14651858.CD003481.pub523633310]Search in Google Scholar
[69. Benitz WE. Patent ductus arteriosus: to treat or not to treat? Arch Dis Child Fetal Neonatal Ed. 2012;97:F80-2. doi: 10.1136/archdischild-2011-300381.10.1136/archdischild-2011-30038122174019]Search in Google Scholar
[70. Marshall DD, Kotelchuck M, Young TE, Bose CL, Kruyer L, O’Shea TM. Risk factors for chronic lung disease in the surfactant era: a North Carolina population-based study of very low birth weight infants. North Carolina Neonatologists Association. Pediatrics. 1999;104:1345-50.10.1542/peds.104.6.134510585987]Search in Google Scholar
[71. Noerr B. Current controversies in the understanding of necrotizing enterocolitis Part 1. Adv Neonatal Care. 2003;3:107-20.]Search in Google Scholar
[72. Shortland DB, Gibson NA, Levene MI, Archer LNJ, Evans DH, Shaw DE. Patent ductus arteriosus and cerebral circulation in preterm infants. Dev Med Child Neurol. 1990;32:386-93.10.1111/j.1469-8749.1990.tb16957.x2354752]Search in Google Scholar
[73. Ibrahim TK, Haium AAA, Chandran S, Rajadurai VS. Current Controversies in the Management of Patent Ductus Arteriosus in Preterm Infants. Indian Pediatr. 2014;51:289-94.10.1007/s13312-014-0403-224825266]Search in Google Scholar